Join us in Las Vegas for this

Midday Symposium Conducted at the 2022 ASHP Midyear Clinical Meeting & Exhibition!

Clinical Decision-making in Prevention and Management of Clostridioides difficile Infection (CDI)

CDI is the most common healthcare-associated infection and the most common cause of increased morbidity, mortality, and healthcare costs. Recent updates to guidelines have resulted in practitioners having varying treatment and management options for CDI. This activity explores these guideline updates and their application, with a focus on treatment and management of CDI, as well as the pharmacoeconomic and quality-of-life impacts of CDI.

Monday, Dec. 5

11:30 a.m. - 1 p.m. PT

Come early! Seating is limited and provided on a first-come, first-served basis.

Symposium Location: Islander Ballroom I, Lower Level, Mandalay Bay North Convention Center

Can't make it to Vegas? Tune into the Live Webinar Broadcast: 

Monday, Dec. 5

11:30 a.m. - 1 p.m. PT (2:30 - 4 p.m. ET)

Registration is required for the webinar.

Featuring...

Anne Gonzales-Luna

PharmD, BCIDP
Activity Chair

Research Assistant Professor - Infectious Diseases
University of Houston College of Pharmacy
Houston, Texas

Andrew Skinner

MD

Assistant Professor of Medicine
Loyola University Medical Center
Staff Physician and Research
Edward Hines Jr., VA Hospital
Maywood, Illinois

Target Audience

This activity was planned to meet the educational needs of pharmacists and physicians who care for patients with CDI.

Learning Objectives

• Identify the complex epidemiology and pathogenesis of recurrent CDI.
• Analyze recently released therapeutic guidelines and recommendations for the treatment of primary and recurrent CDI in adults.
• Develop an interprofessional treatment plan for recurrent CDI.
• Evaluate the quality-of-life impacts of CDI on patient.

Agenda

11:30 am - Welcome and Introductions
Anne Gonzales-Luna, PharmD, BCIDP

11:35 am - Discuss the Epidemiology and Pathogenesis of CDI
Andrew Skinner, MD, Anne Gonzales-Luna, PharmD, BCIDP

11:50 am - Discussion of Recent Guidelines and Recommendations for CDI
Andrew Skinner, MD, Anne Gonzales-Luna, PharmD, BCIDP

12:10 pm - Discussion of Interprofessional Treatment Plans for CDI
Andrew Skinner, MD, Anne Gonzales-Luna, PharmD, BCIDP

12:30 pm - Discussion of Quality-of-life Impacts of CDI on Patients
Andrew Skinner, MD, Anne Gonzales-Luna, PharmD, BCIDP

12:50 pm - Faculty Discussion/ Questions and Answers in Special Patient Populations- Patient Scenarios and Interprofessional Treatment Plans
Andrew Skinner, MD, Anne Gonzales-Luna, PharmD, BCIDP

Accredited for CPE

ACPE #:0204-0000-22-417-L01-P

CE Credit: 1.5 contact hours (0.15 CEUs)

Activity Type: Application-based

Activity Fee: No charge

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Health-System Pharmacists designates this internet enduring material  for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provided by ASHP.
Supported by an educational grant from Merck.
For questions and assistance to participate, contact us.